Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma
Clinical trial NCT00581776 · COMPLETED
Trial details
- NCT number
- NCT00581776
- Sponsor
- University of Wisconsin, Madison
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2012-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.